Quick Answer
IMMUNIC, INC. reported Stockholders Equity of -$6.67 million for the year ending 2025.
- IMMUNIC, INC. showed a decrease of -136.2% in Stockholders Equity from 2024 to 2025.
- This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: -$44.66 million | Q1 2014: -$58.02 million | Q2 2014: $89.16 million | Q3 2014: $77.05 million | Q1 2015: $83.78 million | Q2 2015: $69.74 million | Q3 2015: $58.68 million | Q1 2016: $78.05 million | Q2 2016: $74.15 million | Q3 2016: $67.76 million | Q1 2017: $84.43 million | Q2 2017: $73.34 million | Q3 2017: $62.08 million | Q1 2018: -$15.57 million | Q2 2018: -$18.97 million | Q3 2018: -$20.80 million | Q1 2019: -$9.77 million | Q2 2019: $69.41 million | Q3 2019: $60.53 million | Q1 2020: $50.49 million | Q2 2020: $78.69 million | Q3 2020: $162.88 million | Q1 2021: $137.45 million | Q2 2021: $120.74 million | Q3 2021: $145.47 million | Q1 2022: $137.96 million | Q2 2022: $127.85 million | Q3 2022: $108.81 million | Q1 2023: $91.22 million | Q2 2023: $69.28 million | Q3 2023: $48.41 million | Q1 2024: $83.58 million | Q2 2024: $63.57 million | Q3 2024: $41.22 million | Q1 2025: -$5.29 million | Q2 2025: $33.91 million | Q3 2025: $10.50 million.
- Over the full 15 years of available data (2011 to 2025), IMMUNIC, INC.'s Stockholders Equity has grown by 87.8%.
- Historical annual values: Fiscal year 2025: -$6.67 million | Fiscal year 2024: $18.43 million | Fiscal year 2023: $28.93 million | Fiscal year 2022: $113.68 million | Fiscal year 2021: $127.12 million | Fiscal year 2020: $158.79 million | Fiscal year 2019: $58.36 million | Fiscal year 2018: -$25.74 million | Fiscal year 2017: -$13.34 million | Fiscal year 2016: $58.45 million | Fiscal year 2015: $82.33 million | Fiscal year 2014: $97.56 million | Fiscal year 2013: -$44.66 million | Fiscal year 2012: -$7.63 million | Fiscal year 2011: -$54.85 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: